GE HealthCare Technologies Inc. which can be found using ticker (GEHC) have now 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 99 and 78 calculating the mean target price we have $89.67. Given that the stocks previous close was at $67.66 and the analysts are correct then we can expect a percentage increase in value of 32.5%. There is a 50 day moving average of $75.47 and the 200 day MA is $74.41. The company has a market cap of 30.47B. The current share price for the company is: 66.98 USD
The potential market cap would be $40,375,425,260 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 18.87, revenue per share of 41.86 and a 5.77% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
